KALV KalVista Pharmaceuticals, Inc. logo

KALV KalVista Pharmaceuticals, Inc.

Healthcare
$26.79+0.07%ClosedMarket Cap: $1.43B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

164

13F Shares

66,955,353

Ownership %

124.3%

New Positions

36

Increased Positions

91

Closed Positions

22

Reduced Positions

48

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBPVirtus Biotech ETF49,9271.80%
SBIOALPS Medical Breakthroughs ETF41,1490.65%
XBI1,077,9520.29%
LABUDirexion Daily S&P Biotech Bull 3X ETF53,9080.20%
IJE96,6590.15%
IWCiShares Micro-Cap ETF96,6590.15%
VFMO52,6470.07%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF76,1350.07%
FESMFidelity Enhanced Small Cap ETF145,6100.07%
IBBiShares Biotechnology ETF276,9160.07%
NLO313,5520.05%
IWOiShares Russell 2000 Growth ETF313,5520.05%
VTWG35,0560.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF47,5540.03%
RSSLGlobal X - Russell 2000 ETF17,4860.02%
NJM942,6130.02%
IWMiShares Russell 2000 ETF942,6130.02%
VTWO190,2370.02%
SCHASchwab U.S. Small-Cap ETF189,4770.02%
ONEQFidelity Nasdaq Composite Index ETF29,8950.01%